Related Experiment Video
Updated: May 28, 2026
06:37
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
Induced pluripotent stem cells in cardiovascular medicine
Toru Egashira1, Shinsuke Yuasa, Keiichi Fukuda
1Department of Cardiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan.
Stem Cells International
|October 7, 2011
Summary
Induced pluripotent stem (iPS) cells offer a promising future for regenerative medicine, particularly in cardiovascular research. Ongoing advancements in iPS cell technology are paving the way for new disease models and potential cell therapies.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Cardiovascular research
Background:
- Induced pluripotent stem (iPS) cells are derived from somatic cells via reprogramming.
- iPS cells possess self-renewal and multi-lineage differentiation potential.
- Ethical and immunological concerns are minimized compared to embryonic stem cells.
Purpose of the Study:
- To summarize the progress of iPS cell technology in cardiovascular research.
- To highlight the potential of iPS cells in regenerative medicine and disease modeling.
- To discuss advancements in generating cardiomyocytes from iPS cells.
Main Methods:
- Reprogramming somatic cells using embryonic stem (ES) cell-specific transcription factors.
- Utilizing viral vectors for transgene introduction (traditional method).
- Developing non-integrative methods to mitigate tumorigenesis risk.
- Advancing techniques for pluripotent stem cell differentiation and purification into cardiomyocytes.
Main Results:
- iPS cells offer potential for regenerative medicine without ethical or immunological issues.
- Non-integrative reprogramming methods are being actively researched due to safety concerns.
- Cardiomyocyte differentiation and purification techniques are continuously improving.
- iPS cell technology enables the creation of human disease models.
Conclusions:
- Cardiomyocyte transplantation using iPS cells shows future promise for cardiovascular regenerative medicine.
- Further research is needed to overcome existing challenges in iPS cell therapy.
- iPS cells are revolutionizing cardiovascular research and disease modeling.
More Related Videos
Related Concept Videos
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...